secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sana Biotechnology, Inc. (SANA)
CIK:        0001770121
Form:       8-K
Filed at:   2024-02-08T23:59:59+00:00
Accession:  0001193125-24-028506
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sana Biotechnology prices upsized $165M public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Sold 17.3M shares at $5.50 and pre-funded warrants for 12.7M shares at $5.4999 each.
- Gross proceeds ~$165M; net proceeds ~$156.6M after underwriting discounts and expenses.
- Underwriters granted 30-day option to purchase additional 4.5M shares.
- Offering expected to close February 12, 2024; Morgan Stanley, J.P. Morgan, Goldman Sachs, BofA are joint book-runners.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770121/000119312524028506/0001193125-24-028506-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770121/000119312524028506/d745670d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-028506

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer